『 Smart MHI News  | Course Speech-  』

March 11, 2023

The Course named " Research Methodology in Smart Medicine" aim to make students understand digital health products,the basic components of clinical researches etc.

We invited the some engineers and doctors who have worked in the Smart Medicine industry for years.

Sharing the real example and the papers, they help students understand digital health devices from R&D, regulation, to clinical application.

On March 4th, Dr. Liu Chung-tse, a researcher from the Industrial Technology Research Institute (ITRI), delivered a lecture on the categories and regulations of digital health devices in Taiwan, specifically focusing on the guidance provided by the Taiwan FDA. The lecture provided valuable insights into the regulatory framework surrounding digital health devices in Taiwan, which is becoming an increasingly important market for medical technology. With the rapid development of digital health devices and their potential to transform healthcare, understanding the regulatory landscape is essential for companies and researchers operating in this field. Dr. Liu's lecture offered a comprehensive overview of the regulations in Taiwan and provided practical guidance on navigating this complex regulatory environment.

On March 11th, Acer Medicine unveiled their latest innovation in smart health technology - the VeriSee AMD - which has the potential to transform the way we diagnose and prevent Age-related Macular Degeneration. As part of the launch event, the project manager of Acer Medicine also delivered a compelling lecture on the topic of Medical AI Business, highlighting the increasing role of artificial intelligence in the healthcare industry.

The lecture shed light on how AI technology is being used to address some of the most pressing challenges in healthcare, such as early diagnosis, disease prevention, and personalized treatment. It also discussed the various applications of AI in the medical field, from analyzing medical images and data to developing new drugs and therapies. With the increasing adoption of AI in healthcare, the lecture also explored the potential benefits and risks of this technology, and how companies like Acer Medicine are leveraging AI to improve patient outcomes.

Overall, the lectures on ITRI and Medical AI Business were a thought-provoking and informative session that offered valuable insights into the role of AI in healthcare and the innovative solutions being developed by Acer Medicine to improve the lives of patients worldwide.